Search

Search Results

• HAQ-DI Italian version in systemic sclerosis

  G. La Montagna, G. Cuomo, I. Chiarolanza, L. Ruocco, G. Valentini

  112-115

  https://doi.org/10.4081/reumatismo.2006.112

  1502

  PDF: 1921
• 

  Frequency of ANA/DFS70 autoantibodies in Colombian patients with undifferentiated connective tissue disease

  D. Rincón-Riaño, D.G. Fernández-Ávila, D. Acero-Molina, J.M. Bello Gualtero , C. Romero-Sánchez

  13-09-2022

  https://doi.org/10.4081/reumatismo.2022.1420

  1393

  PDF: 781
• 

  Diagnostic and prognostic role of renal histopathology in rheumatic diseases

  F. Saccon, M. Gatto, M. Larosa, F. Ometto, M. Felicetti, R. Padoan, M. Zen

  165-177

  03-10-2018

  https://doi.org/10.4081/reumatismo.2018.1064

  2216

  PDF: 1552

• How to prescribe physical exercise in rheumatology

  S. Maddali Bongi, A. Del Rosso

  4-11

  https://doi.org/10.4081/reumatismo.2010.4

  4126

  PDF: 3000
• 

  Observations about subcalcaneal adventitial bursitis (heel fat pad inflammatory lesion) in rheumatoid arthritis. Comment on the article of Suzuki and Shirai

  P. Falsetti, E. Conticini, C. Baldi, C. Acciai, R. D'Alessandro, M. Bardelli, L. Cantarini, B. Frediani

  182-183

  19-11-2020

  https://doi.org/10.4081/reumatismo.2020.1282

  700

  PDF: 607

• Farmacoeconomic impact of anti-TNFα

  G. Leardini, C. Bernardi, E. Vaccaro

  80-86

  https://doi.org/10.4081/reumatismo.2004.1s.80

  827

  PDF: 638

• Role of omega-3 polyunsaturated fatty acids in diet of patients with rheumatic diseases

  C. Sales, F. Oliviero, P. Spinella

  95-101

  https://doi.org/10.4081/reumatismo.2008.95

  2533

  PDF: 1778

• Pulmonary hypertension in autoimmune rheumatic diseases

  B. Marasini, M. Massarotti, R. Cossutta, L. Massironi, A. Mantero

  114-118

  https://doi.org/10.4081/reumatismo.2005.114

  869

  PDF: 2718

• Detection of serum anti-B/B’ UsnRNP antibodies in patients with connective tissue diseases by immunoblotting

  A. Ghirardello, A. Doria, S. Zampieri, D. Villalta, R. Tozzoli, L. Iaccarino, R. Bendo, P.F. Gambari

  324-330

  https://doi.org/10.4081/reumatismo.2002.324

  878

  PDF: 2664

• Are there any positive effects of TNF-alpha blockers on bone metabolism?

  B. Seriolo, S. Paolino, A. Sulli, M. Cutolo

  199-205

  https://doi.org/10.4081/reumatismo.2006.199

  1215

  PDF: 1121
• 

  COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

  Z. Ahmadinejad, R. Assari, N. Ayoobi Yazdi, S.-H. Mazloomi, P. Javanshayani, H. Khalili Afousi, V. Ziaee

  173-177

  19-11-2020

  https://doi.org/10.4081/reumatismo.2020.1289

  1592

  PDF: 991

• Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis

  M. Fabris, L. Quartuccio, S. Lombardi, M. Benucci, M. Manfredi, M. Saracco, F. Atzeni, P. Morassi, M.A. Cimmino, E. Pontarini, C. Fabro, R. Pellerito, P. Sarzi-Puttini, M. Cutolo, A. Carletto, L.M. Bambara, F. Fischetti, F. Curcio, E. Tonutti, S. De VIta

  253-258

  https://doi.org/10.4081/reumatismo.2010.253

  2053

  PDF: 821

• The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases

  P. Quattrocchi, A. Barrile, D. Bonanno, L. Giannetto, M. Patafi, V. Tigano, B. Ferlazzo

  109-113

  https://doi.org/10.4081/reumatismo.2005.109

  976

  PDF: 3781
• 

  Is CDAI comparable to DAS 28 and SDAI regarding inter-observer agreement and correlation to MHAQ in Egyptian RA patients?

  K. El-Hadidi, S.M. Gamal, S. Saad, N.Y. Elsaid

  203-208

  28-01-2020

  https://doi.org/10.4081/reumatismo.2019.1222

  1802

  PDF: 832

• Do we have markers to define the cardiovascular risk in rheumatoid arthritis patients?

  F. Atzeni, P. Sarzi-Puttini

  1-3

  https://doi.org/10.4081/reumatismo.2009.1

  1496

  PDF: 696
• 

  Can restless legs be a sign of something else? A case report of spondyloarthritis presenting with restless legs syndrome and a review of the literature

  E. Yılmaz

  19-12-2023

  https://doi.org/10.4081/reumatismo.2023.1557

  1938

  PDF: 570

• New classification criteria for rheumatoid arthritis

  C.A. Scirè, R. Caproali

  159-162

  https://doi.org/10.4081/reumatismo.2010.159

  2041

  PDF: 8945

• Migraine in SLE: role of antiphospholipid antibodies and Raynaud’s phenomenon

  Virginia Annese, Paola Tomietto, Paolo Venturini, Serena D'Agostini, Gianfranco Ferraccioli

  50-58

  https://doi.org/10.4081/reumatismo.2006.50

  847

  PDF: 1971
• 

  Comment to: Disseminated cutaneous herpes simplex, COVID-19 vaccination and rheumatoid arthritis patient: a case report and review

  B. Joob, V. Wiwanitkit

  29-12-2022

  https://doi.org/10.4081/reumatismo.2022.1527

  732

  PDF: 313

• Rheumatic diseases at the court of the Medici of Florence: the so-called “gout” of the Medici

  G. Fornaciari, V. Giuffra

  229-237

  https://doi.org/10.4081/reumatismo.2009.229

  1040

  PDF: 797

• Alexithymia and immunoendocrine parameters in patients affected by systemic lupus erythematosus and rheumatoid arthritis

  M. Vadacca, R. Bruni, F. Caccipaglia, F. Serino, L. Arcarese, F. Buzzulini, G. Coppolino, A. Rigon, N. Terminio, A. Afeltra

  50-56

  https://doi.org/10.4081/reumatismo.2008.50

  1891

  PDF: 1061

• A comparison between the Simplified Disease Activity Index (SDAI) and the Disease Activity Score (DAS28) as measure of response to treatment in patients undergoing different therapeutic regimens

  Giovanna Cuomo, Gabriella Molinaro, Giovanni La Montagna, Sergio Migliaresi, Gabriele Valentini

  22-25

  https://doi.org/10.4081/reumatismo.2006.22

  1509

  PDF: 1967